Therefore, our aim was to investigate how T1D changes tissue distribution of CYP27B1 and VDR and whether vitamin D3 (cholecalciferol) treatment can affect diabetes-related dysfunction of the vitamin D-endo/para/autocrine system. This evidence concerns the gene CYP27B1 and diabetes mellitus.